Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Lead-acid Battery Scrap , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Lead-acid Battery Scrap market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Collection & Segregation
Pyrometallurgical Treatment
Hydrometallurgical Treatment
Others
By End-User / Application
Automotive
Power Industry
Telecom Sector
Others
By Company
Umicore
GEM
Brunp Recycling
Battery Solutions
Gravita India
Aqua Metals
AMIDT Group
Engitec Technologies
ECOBAT Technologies
SUNLIGHT Recycling
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Neurologic Disorders Therapeutics Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Neurologic Disorders Therapeutics Market and Growth by Type
1.3 by End-Use / Application
Table Global Neurologic Disorders Therapeutics Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Neurologic Disorders Therapeutics Revenue (Million USD) by Vendors (2017-2019)
Table Global Neurologic Disorders Therapeutics Revenue Share by Vendors (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume (Volume) by Vendors (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume (Volume) by Type (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume (Volume) by Regions (2017-2019)
Table Global Neurologic Disorders Therapeutics Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table North America Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table North America Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table North America Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table Europe Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table Europe Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table South America Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table South America Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Neurologic Disorders Therapeutics Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Neurologic Disorders Therapeutics Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Neurologic Disorders Therapeutics Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Neurologic Disorders Therapeutics Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Neurologic Disorders Therapeutics Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neurologic Disorders Therapeutics Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Neurologic Disorders Therapeutics Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Neurologic Disorders Therapeutics Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Neurologic Disorders Therapeutics Market (Million USD) Forecast by Regions (2020-2025)
Table Global Neurologic Disorders Therapeutics Market Share Forecast by Regions (2020-2025)
Table Global Neurologic Disorders Therapeutics Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Neurologic Disorders Therapeutics Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Neurologic Disorders Therapeutics Market (Million USD) Forecast by Type (2020-2025)
Table Global Neurologic Disorders TherapeuticsMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Neurologic Disorders Therapeutics Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Neurologic Disorders Therapeutics Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.SGS S.A. (Switzerland) Biogen Inc.
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Biogen Inc.
12.2 F. Hoffmann-La Roche Ltd.
12.3 Johnson & Johnson Services Inc.
12.4 Novartis AG
12.5 Pfizer Inc.
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion
Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market:
The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...
Overview of the Global Antibody Based Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Antibody Based Therapeutics Market during the forecast period 2023-2030. ...
Overview of the Global Office-Based Sleep Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Office-Based Sleep Therapeutics Market during the forecast period 202...
Overview of the Global Gastrointestinal Disorders Treatment:
The report discusses everything a marketer requires before investing in the global Gastrointestinal Disorders Treatment during the forecast period 2023-20...
Overview of the Global Digital Therapeutics Navigation Platform Market:
The report discusses everything a marketer requires before investing in the global Digital Therapeutics Navigation Platform Market during the f...
Overview of the Global Substance Abuse Disorder Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Substance Abuse Disorder Therapeutics Market during the forecas...
Overview of the Global Patient-Specific Cancer Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Patient-Specific Cancer Therapeutics Market during the forecast ...
Description
The Nucleic Acid Based Therapeutics Market is poised for significant growth, with a projected expansion from USD 4.28 billion in 2022 to USD 9.51 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 11.6% during the forecast period of 2023-2029. This market pr...
Executive Summary
Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonis...
Overview of the Global Drugs to Treat Urea Cycle Disorders Market:
The report discusses everything a marketer requires before investing in the global Drugs to Treat Urea Cycle Disorders Market during the forecast pe...